Health Policy | ARMA

How integrated care is set to improve outcomes for those with comorbidities

Guest blog by William Pett – Senior Policy Advisor, NHS Confederation

As people grow older, health conditions often become both more complex and chronic. Evidence shows that rates of those living with multimorbidity rise significantly with age; a recent study revealed that 30% of adults aged 45 to 64 years report at least two chronic conditions, increasing to 65% of adults aged 65 to 84 years and more than 80% for those above 85 years old.

For older people living with multimorbidity, musculoskeletal conditions are common.…

Read more of this article

MSK health – not just doctors and nurses

CEO update by Sue Brown, ARMA

The general election is now in full swing. In amongst the Brexit debate, the NHS has been getting quite a bit of attention, albeit somewhat narrow in focus. I hope that after the election, whoever is in government, this debate will widen so that we can talk about health, not just the NHS, about more than hospitals, doctors and nurses.

One other thing an election brings is restrictions on what government bodies are allowed to do.…

Read more of this article

Guest blog: The fight against fragility fractures

by Ellie Davies, Acting Project Manager, Falls and Fragility Fracture Audit Programme (FFFAP)

The challenge:

520,000 cases of fragility fracture occur every year amongst those (primarily over-50s) suffering with the bone-weakening disease known as osteoporosis. That is 520,000 broken bones caused by as little as slipping in the shower, stepping off a curb even. This is not only a huge economic burden on the NHS, approximately £5.25 billion, but an epidemic that has lasting physical and emotional repercussions for sufferers. It is upsetting to learn that 42% of older people say that osteoporosis has made them feel more socially isolated.…

Read more of this article

NICE guideline on safe prescribing and withdrawal management

NICE guideline: Safe prescribing and withdrawal management of prescribed drugs associated with dependence and withdrawal

The final scope and equality impact assessment for this NICE guideline have now been published, along with all the stakeholder comments that were received during consultation and our responses to these comments.

NICE identified ARMA as a stakeholder for this topic and ARMA is able to comment on the draft guideline when it is available. Please contact us should you have an interest in this topic and are a member.…

Read more of this article

NICE guideline on workplace health

Workplace health: long-term sickness absence and capability to work

NICE published this final guideline on the NICE website. You can also find the supporting evidence, tools and resources as well as all the stakeholder comments NICE received during consultation and the responses to these comments.

The recommendations from this guideline have been included in the NICE Pathway on Managing long-term sickness absence and capability to work, which brings together everything NICE said on Workplace health: long-term sickness absence and capability to work in an interactive flowchart.…

Read more of this article

Medical Devices Regulation and waiting times

Medical Devices Regulation from 2020

On 26 May 2017 the Medical Devices Regulation (MDR 2017/745) was published, with the aim of replacing the current Medical Devices Directive (MDD 93/43/EC). Following a transition period of three years, this regulation will be applied in full from 26 May 2020.

The BOA has recently published its position statement on the MDR. They welcome the drive to improve the rigour and regulation of novel devices and procedures for the benefit of patients. However, the BOA raises some particular concerns with regard to legacy devices, regulation of different types of device, value of registry data in evaluating devices and long term monitoring.…

Read more of this article

Versus Arthritis: responses to consultations

Versus Arthritis have made available their responses to recent consultations and governmental health proposals.

In particular, you can read November’s response to the HM Government consultation ‘Advancing our health: prevention in the 2020s’, and the joint submission document, sent alongside other charities and health organisations, to highlight the urgent need for increased, sustainable public health funding.

Visit the Versus Arthritis Consultation Responses page.

NICE: Guselkumab for treating active psoriatic arthritis

Draft Scope Consultation

The National Institute for Health and Care Excellence (NICE) has been asked to consider an appraisal of guselkumab for treating active psoriatic arthritis after inadequate response to DMARDs ID1658.

NICE invited organisations to take part in the consultation to discuss the draft remit and scope. The organisations selected as stakeholders are listed here and the draft scope that is being consulted on can be found here.

The consultation closes on Wednesday 18 December 2019. If you have any queries regarding this scoping exercise or would like to be involved you can contact Michelle Adhemar, Scoping Project Manager at scopingta@nice.org.uk…

Read more of this article

National Academy for Social Prescribing

October saw the launch of a new National Academy for Social Prescribing (NASP), to champion social prescribing and the work of local communities in connecting people for wellbeing. Its objectives include exploring new ways of sourcing statutory and non-statutory funding and brokering relationships between different sectors. Given the prevalence of MSK conditions, it is important that social prescribing has something to offer for MSK.

The NHS Long Term Plan includes plans to recruit over 1,000 trained social prescribing link workers by 2020 to 2021, with the aim of 900,000 people being referred to social prescribing schemes by then.…

Read more of this article

ARMA, PHE and the Centre for Ageing Better

ARMA joins Public Health England and the Centre for Ageing Better to make England the best place to grow old, because musculoskeletal health is vital to healthy ageing.

ARMA joined over sixty high-profile organisations in the UK’s health, housing, employment, research and voluntary sectors to launch a landmark shared vision on healthy ageing.

There are five key principles: prioritising prevention and public health; creating opportunities for people to contribute to society as they age; fostering accessible and inclusive homes and neighbourhoods so everyone can live where they want; narrowing inequalities in healthy ageing; and challenging ageist language, culture and practices.…

Read more of this article